Application of a novel nucleic acid structure immune activation composition as adjuvant for nasal spray vaccines
The combination of CpG-2722 and 2’3’-c-di-AM(PS)2 exhibited a cooperative adjuvant effect for SARS-CoV-2 RBD vaccines and a favorable safety profile in the nasal cavities of mice. CpG-2722/cyclic dinucleotide combinations enhanced the performance of nasal H7 influenza vaccines. Nasal administration of these combination-adjuvanted shingles vaccines elicited a superior vaccine response compared to intramuscularly injected Shingrix, indicating the superior adjuvant activity of these combinations.
Administration with recombinant fragment of human SP-D (rfhSP-D) in t he diagnosis and treatment for chronic obstructive pulmonary disease
Integration of intelligent transcranial magnetic stimulation and language -cognitive VR training system
Demonstration of a Superior Deep-UV Surface-Enhanced Resonance Ram an Scattering (SERRS) Substrate and Single-Base Mutation Detection in O ligonucleotides
Development of novel cannabinoid CB1receptor antagonists with high oral absorption and no central adverse effects for the treatment of cardiovascular diseases
Technology maturity：Experiment stage
Exhibiting purpose：Display of scientific results
Trading preferences：Negotiate by self
Coming soon!